- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
In vitro drug testing using patient-derived ovarian cancer organoids ; volume:17 ; number:1 ; day:2 ; month:10 ; year:2024 ; pages:1-12 ; date:12.2024
Journal of ovarian research ; 17, Heft 1 (2.10.2024), 1-12, 12.2024
- Urheber
-
Chen, Lin-Yu
Chou, Yu-Ting
Liew, Phui-Ly
Chu, Ling-Hui
Wen, Kuo-Chang
Lin, Shiou-Fu
Weng, Yu-Chun
Wang, Hui-Chen
Su, Po-Hsuan
Lai, Hung-Cheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-024-01520-2
- URN
-
urn:nbn:de:101:1-2502192102241.037081847468
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Lin-Yu
- Chou, Yu-Ting
- Liew, Phui-Ly
- Chu, Ling-Hui
- Wen, Kuo-Chang
- Lin, Shiou-Fu
- Weng, Yu-Chun
- Wang, Hui-Chen
- Su, Po-Hsuan
- Lai, Hung-Cheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: In vitro drug testing using patient-derived ovarian cancer organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing
Correction: In vitro drug testing using patient-derived ovarian cancer organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing
Correction: In vitro drug testing using patient-derived ovarian cancer organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies